WM-1120 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor targeting specific cellular pathways involved in tumor growth and proliferation. Researchers employ WM-1120 to investigate its efficacy in halting the progression of various cancer types, including breast and lung cancers. Its application extends to preclinical studies where it is used to evaluate the potential for developing new anticancer drugs. Additionally, WM-1120 is instrumental in understanding the molecular mechanisms underlying cancer cell resistance to conventional treatments, thereby aiding in the design of more effective therapeutic strategies.